2 news items
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
CMMB
17 May 24
recruitment of hepatic stellate cells, monocytes and neutrophils and modulates hepatic
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update
CMMB
7 Mar 24
&A expenses reflected selected reductions in headcount, and reductions in share-based payments and recruitment costs
- Prev
- 1
- Next